Merck (MRK) news
Recent news
S&P 500, Nasdaq 100 gain to session highs
On August 28, 2026, the S&P 500 and Nasdaq 100 reached session highs, driven by continued strength in the technology sector and optimism around AI infrastructure demand. The S&P 500 rose 0.15% to 7742 points, while the Nasdaq 100 maintained gains despite trimming some of the previous day’s…
AInvest Wire · 11h agoModerna shares fall over 5%, Merck & Co. declines 2.2%
Moderna (MRNA) shares fell more than 5% in early trading on August 28, 2026, while Merck & Co. (MRK) declined by 2.2%. The drop follows a period of strong performance for both companies, with Merck having returned 126.6% over the past five years and Moderna experiencing a 177% surge in a single day…
AInvest Wire · 13h agoModerna shares fall over 5%, Merck & Co. declines 2.2%
Moderna (MRNA) shares fell more than 5% in early trading on August 28, 2026, while Merck & Co. (MRK) declined by 2.2%. The drop follows a period of strong performance for both companies, with Merck having returned 126.6% over the past five years and Moderna experiencing 177% surge in a single day…
AInvest Wire · 13h agoChongqing Zhifei Biological Products H1 net loss at 808.5 mln yuan
Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ) reported net loss of 808.5 million yuan for the first half of 2026, according to its interim report released on April 28, 2026. This represents a continuation of the company’s financial struggles, which were highlighted earlier in the year…
AInvest Wire · 15h agoKelun Pharma. 1H net income 1.13B yuan
Kelun-Biotech (HKEX: 6990.HK) reported a net income of RMB 1.13 billion for the first half of 2023, driven by a significant increase in revenue and a narrowing of its period loss. The company’s revenue for the six months ended June 30, 2023, reached approximately RMB 1,046 million, representing a…
AInvest Wire · 2d agoLight Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.